Authors' Reply: Efficacy of methyprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson’s disease
- PMID: 31038298
Authors' Reply: Efficacy of methyprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson’s disease
Retraction in
-
Retraction.J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):e3. doi: 10.1136/jnnp.74.5.0574ret. Epub 2018 Jan 25. J Neurol Neurosurg Psychiatry. 2018. PMID: 29483131 Free PMC article. No abstract available.
Comment on
-
Efficacy of methylprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's disease.J Neurol Neurosurg Psychiatry. 2003 May;74(5):574-6. doi: 10.1136/jnnp.74.5.574. J Neurol Neurosurg Psychiatry. 2003. Retraction in: J Neurol Neurosurg Psychiatry. 2018 Dec;89(12):e9. doi: 10.1136/jnnp.74.5.574ret. PMID: 12700295 Free PMC article. Retracted. Clinical Trial.
-
Efficacy of methyprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's disease.J Neurol Neurosurg Psychiatry. 2004 Mar;75(3):510-1; author reply 511. J Neurol Neurosurg Psychiatry. 2004. PMID: 14966183 Free PMC article. No abstract available.
Publication types
LinkOut - more resources
Full Text Sources